Skip to main content
Erschienen in: Diabetologia 3/2018

01.12.2017 | Article

Adapting to insulin resistance in obesity: role of insulin secretion and clearance

verfasst von: Sang-Hee Jung, Chan-Hee Jung, Gerald M. Reaven, Sun H. Kim

Erschienen in: Diabetologia | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to quantify the relative contributions of increased insulin secretion rate (ISR) and decreased insulin clearance rate (ICR) in the compensatory hyperinsulinaemia characteristic of insulin-resistant individuals without diabetes.

Methods

Obese (BMI ≥30 kg/m2) individuals without diabetes (n = 91) were identified from a registry of volunteers. Volunteers underwent the following measurements: oral glucose tolerance; insulin resistance (steady-state plasma glucose [SSPG] concentration during the insulin suppression test [IST]); ISR (using the graded glucose infusion test [GGIT]); and ICR (using the IST and GGIT). Participants were stratified into tertiles based on SSPG concentration: SSPG-1(insulin-sensitive); SSPG-2 (intermediate); and SSPG-3 (insulin-resistant).

Results

There were no differences in BMI and waist circumference among the SSPG tertiles. Serum alanine aminotransferase concentrations were higher in the SSPG-2 and SSPG-3 groups compared with the SSPG-1 group (p = 0.02). Following an oral glucose challenge, there was a progressive increase in the total integrated insulin response from the most insulin-sensitive to the most insulin-resistant tertiles (p < 0.001). Following intravenous glucose, the SSPG-3 group had significantly greater integrated glucose (median [interquartile range], 32.9 [30.8–36.3] mmol/l × h) and insulin responses (1711 [1476–2223] mmol/l × h) compared with the SSPG-1 group (30.3 [28.8–32.9] mmol/l × h, p = 0.04, and 851 [600–1057] pmol/l × h, p < 0.001, respectively). Furthermore, only the SSPG-3 group had significant changes in both ISR and ICR (p < 0.001). In the SSPG-2 group, only the ICR was significantly decreased compared with the SSPG-1 group. Therefore, ICR progressively declined during the IST with increasing insulin resistance (SSPG-1, 0.48 [0.41–0.59]; SSPG-2, 0.43 [0.39–0.50]; SSPG-3, 0.34 [0.31–0.40]).

Conclusions/interpretation

While both increases in ISR and decreases in ICR compensate for insulin resistance, decreases in ICR may provide the first adaptation to decreased insulin sensitivity.
Literatur
1.
Zurück zum Zitat Skyler JS, Bakris GL, Bonifacio E et al (2017) Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 66:241–255CrossRefPubMed Skyler JS, Bakris GL, Bonifacio E et al (2017) Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 66:241–255CrossRefPubMed
2.
Zurück zum Zitat Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM (1997) Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82:1834–1838CrossRefPubMed Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM (1997) Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82:1834–1838CrossRefPubMed
3.
Zurück zum Zitat American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62–S69CrossRefPubMedCentral American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62–S69CrossRefPubMedCentral
4.
Zurück zum Zitat Pei D, Jones CN, Bhargava R, Chen YD, Reaven GM (1994) Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37:843–845CrossRefPubMed Pei D, Jones CN, Bhargava R, Chen YD, Reaven GM (1994) Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37:843–845CrossRefPubMed
5.
Zurück zum Zitat Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G (1981) Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387–392CrossRefPubMed Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G (1981) Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387–392CrossRefPubMed
6.
Zurück zum Zitat Knowles JW, Assimes TL, Tssao PS et al (2013) Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp. Metabolism 62:548–553CrossRefPubMed Knowles JW, Assimes TL, Tssao PS et al (2013) Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp. Metabolism 62:548–553CrossRefPubMed
7.
Zurück zum Zitat Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM (2000) Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278:E501–E508CrossRefPubMed Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM (2000) Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278:E501–E508CrossRefPubMed
8.
Zurück zum Zitat Kim SH, Abbasi F, Chu JW et al (2005) Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals. Diabetes 54:2447–2452CrossRefPubMed Kim SH, Abbasi F, Chu JW et al (2005) Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals. Diabetes 54:2447–2452CrossRefPubMed
9.
Zurück zum Zitat Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377CrossRefPubMed Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377CrossRefPubMed
10.
11.
Zurück zum Zitat Kim S, Liu A, Ariel D et al (2014) Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study. Diabetes Care 37:1–7CrossRef Kim S, Liu A, Ariel D et al (2014) Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study. Diabetes Care 37:1–7CrossRef
12.
Zurück zum Zitat Polidori DC, Bergman RN, Chung ST, Sumner AE (2016) Hepatic and extrahepatic insulin clearance are differentially regulated: results from a novel model-based analysis of intravenous glucose tolerance data. Diabetes 65:1556–1564CrossRefPubMedPubMedCentral Polidori DC, Bergman RN, Chung ST, Sumner AE (2016) Hepatic and extrahepatic insulin clearance are differentially regulated: results from a novel model-based analysis of intravenous glucose tolerance data. Diabetes 65:1556–1564CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Polonsky KS, Given BD, Hirsch L et al (1988) Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435–441CrossRefPubMedPubMedCentral Polonsky KS, Given BD, Hirsch L et al (1988) Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435–441CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bonora E, Zavaroni I, Bruschi F et al (1984) Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 59:1121–1127CrossRefPubMed Bonora E, Zavaroni I, Bruschi F et al (1984) Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 59:1121–1127CrossRefPubMed
15.
Zurück zum Zitat Meistas MT, Margolis S, Kowarski AA (1983) Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Phys 245:E155–E159 Meistas MT, Margolis S, Kowarski AA (1983) Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Phys 245:E155–E159
16.
Zurück zum Zitat Kim MK, Reaven GM, Kim SH (2017) Dissecting the relationship between obesity and hyperinsulinemia: role of insulin secretion and insulin clearance. Obesity 25:378–383CrossRefPubMed Kim MK, Reaven GM, Kim SH (2017) Dissecting the relationship between obesity and hyperinsulinemia: role of insulin secretion and insulin clearance. Obesity 25:378–383CrossRefPubMed
17.
Zurück zum Zitat Kim SP, Ellmerer M, Kirkman EL, Bergman RN (2007) Beta-cell “rest” accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model. Am J Physiol Endocrinol Metab 292:E1581–E1589CrossRefPubMed Kim SP, Ellmerer M, Kirkman EL, Bergman RN (2007) Beta-cell “rest” accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model. Am J Physiol Endocrinol Metab 292:E1581–E1589CrossRefPubMed
18.
Zurück zum Zitat Choudhury J, Sanyal AJ (2004) Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis 8:575–594CrossRefPubMed Choudhury J, Sanyal AJ (2004) Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis 8:575–594CrossRefPubMed
19.
Zurück zum Zitat Duckworth WC, Bennett RG, Hamel FG (1998) Insulin degradation: progress and potential. Endocr Rev 19:608–624PubMed Duckworth WC, Bennett RG, Hamel FG (1998) Insulin degradation: progress and potential. Endocr Rev 19:608–624PubMed
20.
Zurück zum Zitat Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H (2007) Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 293:E1709–E1715CrossRefPubMed Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H (2007) Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 293:E1709–E1715CrossRefPubMed
21.
Zurück zum Zitat Cavaghan MK, Ehrmann DA, Polonsky KS (2000) Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106:329–333CrossRefPubMedPubMedCentral Cavaghan MK, Ehrmann DA, Polonsky KS (2000) Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106:329–333CrossRefPubMedPubMedCentral
Metadaten
Titel
Adapting to insulin resistance in obesity: role of insulin secretion and clearance
verfasst von
Sang-Hee Jung
Chan-Hee Jung
Gerald M. Reaven
Sun H. Kim
Publikationsdatum
01.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 3/2018
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4511-0

Weitere Artikel der Ausgabe 3/2018

Diabetologia 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.